Symbicort Drug Profile 2023

SYMBICORT Drug Profile, 2023

This report focuses on SYMBICORT and covers the following critical aspects of this drug:

• United States patents
• Expired United States patents
• District Court patent litigation
• Patent Trial and Appeal Board (PTAB) patent cases
• European supplementary protection certificates (SPCs)
• Clinical trials
• Drug prices
• Annual sales revenues
• Finished product suppliers

ADVAIR HFA Drug Profile, 2023

This report focuses on ADVAIR HFA and covers the following critical aspects of this drug:

• United States patents
• Expired United States patents
• District Court patent litigation
• Patent Trial and Appeal Board (PTAB) patent cases
• European supplementary protection certificates (SPCs)
• Clinical trials
• Drug prices
• Annual sales revenues
• Finished product suppliers
• Raw active pharmaceutical ingredient (API) sources

BREO ELLIPTA Drug Profile, 2023

This report focuses on BREO ELLIPTA and covers the following critical aspects of this drug:

• United States patents
• Expired United States patents
• District Court patent litigation
• European supplementary protection certificates (SPCs)
• Clinical trials
• Drug prices
• Annual sales revenues
• Finished product suppliers

EDURANT Drug Profile, 2023

This report focuses on EDURANT and covers the following critical aspects of this drug:

• United States patents
• Expired United States patents
• District Court patent litigation
• European supplementary protection certificates (SPCs)
• Clinical trials
• Drug prices
• Finished product suppliers
• Raw active pharmaceutical ingredient (API) sources

KAZANO Drug Profile, 2023

This report focuses on KAZANO and covers the following critical aspects of this drug:

• United States patents
• Expired United States patents
• FDA Paragraph IV patent challenges
• District Court patent litigation
• European supplementary protection certificates (SPCs)
• Clinical trials
• Drug prices
• Finished product suppliers

The worldwide gold standard for lactation support professionals Developed by world leaders in lactational pharmacology, this essential reference contains the most current, complete, and evidence-based information available on the transmission of maternal drugs into human milk. It thoroughly addresses one of the most commonly asked questions by breastfeeding mothers—which drugs are safe, and which are hazardous for the infant? The new twentieth edition adds 72 new drugs, updates 356 medications with new data, and adds new information to 927 drugs. The resource relies upon the most current evidence-based studies to evaluate the relative risk of commonly used drugs including Dr. Hale's highly renowned Lactation Risk Categories (LRC). Considered indispensable by hundreds of clinicians worldwide, the book lists safe alternatives for drugs one is currently taking or might need to take in the future. For ease of access to information, it includes key points and savvy tips in information boxes, common abbreviations, illustrative diagrams, concise information on evaluating the infant, and more. New to the 2023 Edition: 72 new drugs 356 medications updated with new data 3 drugs with FDA updates 927 medications updated with new information 74 existing drugs with updated LRC NEW TABLES on monoclonal antibodies and migraines New information on Cannabis. Key Features: Delivers current, evidence-based information on over 1300 drugs, diseases, vaccines, syndromes Incorporates recent updates to Dr. Hale's world-renowned LRC Includes key points and savvy tips about breastfeeding and medications for quick reference Lists common abbreviations and drugs in easily-accessible alphabetical order Discusses adult concerns, adult dose, pediatric concerns, infant monitoring, and alternatives Includes succinct information on evaluation of the infant

The quickest, most efficient way for mastering critical facts about common drugs Perfect for NAPLEX and course review, McGraw-Hill's 2020/2021 Top 300 Pharmacy Drug Cards is the most concise and up-to-date resource for building a solid knowledge base of the most commonly used drugs. Each card includes: Generic and common name Dosage Forms Approved Dose and Indications Off-Label Use Contraindications Adverse Reactions Drug Interactions Monitoring Parameters Medication Safety Issues and Black Box Warnings Strong focus on patient safety Adverse reactions are organized by common, less common, and rare but serious to help you organize your thoughts for counseling patients, and a downloadable audio link enable you to hear key information your device.

THE ESSENTIAL WORK IN TRAVEL MEDICINE -- NOW COMPLETELY UPDATED FOR 2018 As unprecedented numbers of travelers cross international borders each day, the need for up-to-date, practical information about the health challenges posed by travel has never been greater. For both international travelers and the health professionals who care for them, the CDC Yellow Book 2018: Health Information for International Travel is the definitive guide to staying safe and healthy anywhere in the world. The fully revised and updated 2018 edition codifies the U.S. government's most current health guidelines and information for international travelers, including pretravel vaccine recommendations, destination-specific health advice, and easy-to-reference maps, tables, and charts. The 2018 Yellow Book also addresses the needs of specific types of travelers, with dedicated sections on: · Precautions for pregnant travelers, immunocompromised travelers, and travelers with disabilities · Special considerations for newly arrived adoptees, immigrants, and refugees · Practical tips for last-minute or resource-limited travelers · Advice for air crews, humanitarian workers, missionaries, and others who provide care and support overseas Authored by a team of the world's most esteemed travel medicine experts, the Yellow Book is an essential resource for travelers -- and the clinicians overseeing their care -- at home and abroad.